CLOUATRE DALLAS L has a total of 11 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, foods and drinks and measurement are ALESCO S R L, GUANGANMEN HOSPITAL CHINA ACAD OF CHINESE MEDICAL SCIENCES and ANHUI JIUHUA & HUAYUAN PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Measurement | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Measuring microorganism processes | |
#5 | Foods | |
#6 | Special foods |
# | Name | Total Patents |
---|---|---|
#1 | Clouatre Dallas L | 11 |
#2 | Dunn James M | 4 |
#3 | Dunn Caroline | 4 |
#4 | Clouatre Daniel E | 2 |
#5 | Bangun Nimpan | 1 |
#6 | Shah Parag | 1 |
Publication | Filing date | Title |
---|---|---|
US2015125887A1 | Method for establishing the anti-diabetic potential of bitter melon | |
WO2008140444A1 | Dimeric double metal salts of(-) hydroxycitric acid, methods of making and uses of same | |
US2007184040A1 | Compositions for delivery of coenzyme Q10 | |
US2007160695A1 | Pharmaceutical preparations for treating hypertension and dyslipidemia with Allium ursinum and Allium sativum | |
US2006025483A1 | (-)-Hydroxycitric acid for protection against soft tissue and arterial calcification | |
US2006025482A1 | (-)-Hydroxycitric acid for the modulation of angiotensin-converting enzyme | |
US8394856B2 | (-)-Hydroxycitric acid for controlling inflammation |